Research suggests that we may have more to thank cinnamon for than just it’s vibrant flavor

With cancer reported to be one of the leading causes of death in, research into prevention and treatment of the disease is abundant and extensive. One compound that has shown promise in preliminary research to help mitigate cancer? Cinnamaldehyde.

The review

A 2023 metanalysis published in Physiologia examined the potential of cinnamaldehyde, a phytochemical and dietary supplement extracted from cinnamon bark, to aid in the prevention and management of certain cancers, including leukemia, colon cancer, and breast cancer.

By examining relevant exploratory studies and literature, the review’s aim was to analyze cinnamaldehyde’s interaction with cancer cells, which causes apoptosis (natural cell death), as well as its potential to inhibit cancer cells from spreading.

The observations

The metanalysis concluded that cinnamaldehyde—when combined in lab studies with conventional anticancer medications—demonstrated potential in aiding the prevention and/or treatment of cancer.

Like other natural compounds, cinnamaldehyde may have various positive effects, such as guiding the immune system to better detect cancer cells. However, more research is needed to determine whether or not this phytochemical could be safely and effectively integrated into clinical practice.

Further benefits

Cinnamaldehyde has demonstrated other potential benefits in exploratory research, including in wound healing, based on its antimicrobial, antioxidant, and anti-inflammatory properties. It has also been studied for a potential role in prevention and/or treatment of cardiovascular diseases and diabetes, as well as a supportive role in maintaining cognitive function.

This article was originally published in the April 2024 issue of delicious living magazine.